1. Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series
   Anna Stein et al, 2022, Frontiers in Oncology CrossRef
2. Myeloid neoplasm with isolated del(5q) and the MPLW515L mutation fulfills the WHO diagnostic criteria for ET
   Keita Kirito, 2020, International Journal of Hematology CrossRef
3. Coincidence of 5q deletion and the JAK2V617F mutation: report of two patients with overlapping myelodysplastic and myeloproliferative features and review of the literature
   Susanne Bürki et al, 2018, Leukemia & Lymphoma CrossRef